119 related articles for article (PubMed ID: 38509444)
1. The effect of race/ethnicity on cancer-specific mortality after trimodal therapy.
de Angelis M; Baudo A; Siech C; Jannello LMI; Di Bello F; Goyal JA; Tian Z; Longo N; de Cobelli O; Chun FKH; Saad F; Shariat SF; Carmignani L; Gandaglia G; Moschini M; Montorsi F; Briganti A; Karakiewicz PI
J Racial Ethn Health Disparities; 2024 Mar; ():. PubMed ID: 38509444
[TBL] [Abstract][Full Text] [Related]
2. Trimodal therapy effect on survival in urothelial vs non-urothelial bladder cancer.
de Angelis M; Baudo A; Siech C; Jannello LMI; Di Bello F; Goyal JA; Tian Z; Longo N; de Cobelli O; Chun FKH; Saad F; Shariat SF; Carmignani L; Gandaglia G; Moschini M; Montorsi F; Briganti A; Karakiewicz PI
BJU Int; 2024 Mar; ():. PubMed ID: 38494989
[TBL] [Abstract][Full Text] [Related]
3. Non-Surgical Bladder-Sparing Multimodal Management in Organ-Confined Urothelial Carcinoma of the Urinary Bladder: A Population-Based Analysis.
de Angelis M; Baudo A; Siech C; Jannello LMI; Di Bello F; Goyal JA; Tian Z; Longo N; de Cobelli O; Chun FKH; Saad F; Shariat SF; Carmignani L; Gandaglia G; Moschini M; Montorsi F; Briganti A; Karakiewicz PI
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610970
[TBL] [Abstract][Full Text] [Related]
4. Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype.
Barletta F; Tappero S; Panunzio A; Incesu RB; Cano Garcia C; Piccinelli ML; Tian Z; Gandaglia G; Moschini M; Terrone C; Antonelli A; Tilki D; Chun FKH; de Cobelli O; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497246
[TBL] [Abstract][Full Text] [Related]
5. The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy.
Wenzel M; Würnschimmel C; Nocera L; Colla Ruvolo C; Hoeh B; Tian Z; Shariat SF; Saad F; Briganti A; Graefen M; Preisser F; Becker A; Mandel P; Chun FKH; Karakiewicz PI
Front Oncol; 2022; 12():874945. PubMed ID: 36059656
[TBL] [Abstract][Full Text] [Related]
6. Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities.
Cano Garcia C; Piccinelli ML; Tappero S; Panunzio A; Barletta F; Incesu RB; Tian Z; Saad F; Briganti A; Terrone C; Shariat SF; Graefen M; Tilki D; Antonelli A; De Cobelli O; Kosiba M; Banek S; Kluth LA; Chun FKH; Karakiewicz PI
Int Urol Nephrol; 2023 May; 55(5):1117-1123. PubMed ID: 36813873
[TBL] [Abstract][Full Text] [Related]
7. The effect of race on stage at presentation and survival in upper tract urothelial carcinoma.
Collà Ruvolo C; Wenzel M; Nocera L; Würnschimmel C; Tian Z; Shariat SF; Saad F; Longo N; Imbimbo C; Briganti A; Mirone V; Karakiewicz PI
Urol Oncol; 2021 Nov; 39(11):788.e7-788.e13. PubMed ID: 34330651
[TBL] [Abstract][Full Text] [Related]
8. Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients.
Horlemann B; Würnschimmel C; Hoeh B; Sorce G; Chierigo F; Flammia RS; Tian Z; Saad F; Briganti A; Shariat SF; Galucci M; Chun FKH; Graefen M; Karakiewicz PI
Clin Genitourin Cancer; 2022 Feb; 20(1):93.e1-93.e9. PubMed ID: 34620567
[TBL] [Abstract][Full Text] [Related]
9. Survival differences in non-seminoma testis cancer patients according to race/ethnicity.
Incesu RB; Barletta F; Tappero S; Piccinelli ML; Garcia CC; Morra S; Scheipner L; Tian Z; Saad F; Shariat SF; Ahyai S; Longo N; Chun FKH; de Cobelli O; Terrone C; Briganti A; Tilki D; Graefen M; Karakiewicz PI
Cancer Epidemiol; 2024 Apr; 89():102538. PubMed ID: 38377946
[TBL] [Abstract][Full Text] [Related]
10. Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities.
Würnschimmel C; Wenzel M; Collà Ruvolo C; Nocera L; Tian Z; Saad F; Briganti A; Shariat SF; Mandel P; Chun FKH; Tilki D; Graefen M; Karakiewicz PI
World J Urol; 2021 Oct; 39(10):3781-3787. PubMed ID: 33978812
[TBL] [Abstract][Full Text] [Related]
11. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
[TBL] [Abstract][Full Text] [Related]
12. The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer.
Wenzel M; Deuker M; Stolzenbach F; Nocera L; Collà Ruvolo C; Tian Z; Shariat SF; Saad F; Briganti A; Kluth LA; Chun FKH; Karakiewicz PI
Urol Oncol; 2021 Jun; 39(6):369.e9-369.e17. PubMed ID: 33309509
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065
[TBL] [Abstract][Full Text] [Related]
14. Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study.
Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Deuker M; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
Clin Genitourin Cancer; 2020 Apr; 18(2):117-128.e5. PubMed ID: 32035800
[TBL] [Abstract][Full Text] [Related]
15. Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at Presentation and Efficacy of Chemotherapy Across All Stages-A SEER-based Study.
Deuker M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Mansour M; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
Eur Urol Focus; 2021 Nov; 7(6):1332-1338. PubMed ID: 32962961
[TBL] [Abstract][Full Text] [Related]
16. Trimodal therapy versus radical cystectomy for cT2N0M0 urothelial muscle-invasive bladder cancer: Single-center experience.
Fallatah M; Alkahtani AS; Alrumayyan M; Alotaibi MF; Alkhateeb S; Mokhtar AA; Altaweel W
Urol Ann; 2023; 15(4):406-411. PubMed ID: 38074180
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer.
Guo Y; Jie X; Zhang A; Zhang W; Wang R; Zhang J; Mao S; Wu Y; Wang L; Zhang Z; Yan Y; Wang P; Yao X
Front Oncol; 2019; 9():1315. PubMed ID: 31867271
[No Abstract] [Full Text] [Related]
18. Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity.
Chierigo F; Borghesi M; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Hoeh B; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Montorsi F; Chun FKH; Shariat SF; Mantica G; Suardi N; Terrone C; Karakiewicz PI
Int Urol Nephrol; 2022 Jul; 54(7):1521-1527. PubMed ID: 35508792
[TBL] [Abstract][Full Text] [Related]
19. Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States.
Cano Garcia C; Nimer N; Piccinelli ML; Tappero S; Panunzio A; Barletta F; Incesu RB; Tian Z; Saad F; Kapoor A; Briganti A; Terrone C; Shariat SF; Tilki D; Antonelli A; De Cobelli O; Kluth LA; Becker A; Chun FKH; Karakiewicz PI
Ann Epidemiol; 2023 Mar; 79():65-70. PubMed ID: 36640918
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients.
Sorce G; Flammia RS; Hoeh B; Chierigo F; Horlemann B; Würnschimmel C; Tian Z; Graefen M; Terrone C; Gallucci M; Chun FKH; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
World J Urol; 2022 Jun; 40(6):1481-1488. PubMed ID: 35084543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
